Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bridging biological cfDNA features and machine learning approaches
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Recent advances of liquid biopsy: Interdisciplinary strategies toward clinical decision‐making
Han Bao, Li Min, Fanqin Bu, et al.
Deleted Journal (2023) Vol. 1, Iss. 4
Open Access | Times Cited: 36
Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma
Iver Nordentoft, Sia V. Lindskrog, Karin Birkenkamp‐Demtröder, et al.
European Urology (2024) Vol. 86, Iss. 4, pp. 301-311
Open Access | Times Cited: 9
Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling
Paul van der Leest, Ed Schuuring
Clinical Chemistry (2024) Vol. 70, Iss. 1, pp. 220-233
Open Access | Times Cited: 8
Surpassing sensitivity limits in liquid biopsy
Tina Moser, Ellen Heitzer
Science (2024) Vol. 383, Iss. 6680, pp. 260-261
Closed Access | Times Cited: 6
Liquid biopsy guides successful molecular targeted therapy of an inoperable pediatric brainstem neoplasm
Cecilia Arthur, Lena-Maria Carlson, J Svoboda, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Systematically Evaluating Cell‐Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns
Yuying Hou, Xiangyu Meng, Xionghui Zhou
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 6
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
Van Thien Chi Nguyen, Trong Hieu Nguyen, Nhu Nhat Tan Doan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 16
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
Van Thien Chi Nguyen, Trong Hieu Nguyen, Nhu Nhat Tan Doan, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 15
Machine learning to detect the SINEs of cancer
Christopher Douville, Kamel Lahouel, Albert Kuo, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 731
Open Access | Times Cited: 4
Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis
Aliki Ntzifa, Evi Lianidou
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 573-594
Closed Access | Times Cited: 10
Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
Jodie Wong, Rohit Muralidhar, Liang Wang, et al.
Biomedical Journal (2024), pp. 100718-100718
Open Access | Times Cited: 3
Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas
B. Korte, Dimitrios Mathios
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4195-4195
Open Access | Times Cited: 3
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Yongjun Cha, Sheehyun Kim, Sae‐Won Han
Cancer Research and Treatment (2023) Vol. 55, Iss. 2, pp. 367-384
Open Access | Times Cited: 8
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection
Su Yeon Kim, Seongmun Jeong, Wookjae Lee, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2445-2460
Open Access | Times Cited: 8
Cell-free and extrachromosomal DNA profiling of small cell lung cancer
Roya Behrouzi, Alexandra Clipson, Kathryn Simpson, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 2
GWAS shows the genetics behind cell-free DNA and highlights the importance of p.Arg206Cys in DNASE1L3 for non-invasive testing
Jasper Linthorst, Michel G. Nivard, Erik A. Sistermans
Cell Reports (2024) Vol. 43, Iss. 10, pp. 114799-114799
Open Access | Times Cited: 2
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
Klaus Pantel, Catherine Alix‐Panabières
Nature Reviews Clinical Oncology (2024) Vol. 22, Iss. 1, pp. 65-77
Closed Access | Times Cited: 2
The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization
Abel J. Bronkhorst, Stefan Holdenrieder
Medizinische Genetik (2023) Vol. 35, Iss. 4, pp. 201-235
Open Access | Times Cited: 6
Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo
Alina A. Filatova, Л. А. Алексеева, Aleksandra V. Sen’kova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5304-5304
Open Access | Times Cited: 1
Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics
Xiaohan Shi, Shiwei Guo, Qiaonan Duan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
AutoCancer as an automated multimodal framework for early cancer detection
Linjing Liu, Ying Xiong, Zetian Zheng, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110183-110183
Open Access | Times Cited: 1
Nanophotonic waveguide-based sensing of circulating cell-free mitochondrial DNA: implications for personalized medicine
Prasan Kaur, Nazim Nazeer, Vikas Gurjar, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104086-104086
Closed Access | Times Cited: 1
The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution
Fırat Özçelik, Mehmet Sait Dündar, Abdulbaki Yildirim, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 4
Closed Access | Times Cited: 1
Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma
Sidney W. Fu, Cong Tang, Xiaohui Tan, et al.
Expert Review of Molecular Diagnostics (2024), pp. 1-19
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top